Thrive Causemetics in Reported Talks with Goldman Sachs Over Buyout

The e-commerce homepage for Thrive Causemetics.
The e-commerce homepage for Thrive Causemetics.

Beauty startup Thrive Causemetics is in reported talks with Goldman Sachs Inc. over a buyout that is said to be valued at several hundred million dollars should the cosmetics brand settle on an agreement with the company, according to Bloomberg.

Further reading: Coty Acquires 20% Stakes in Kim Kardashian West Beauty

The vegan cosmetics brand is reportedly on track to earn about $150 million in revenue this year with $20 million of annual earnings before interest, taxes, depreciation and amortization. 

More in News